Newsroom | 2471 results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (NASDAQ: PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson’s President and Chief Executive Officer, said, “I would like to express my gratitude t...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 7, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Fin...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, May 6, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2025 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations...

LONDON--(BUSINESS WIRE)--Dial A Vet, Australia’s leading telehealth veterinary service, is thrilled to announce its expansion into Canada, the USA, and the UK, bringing affordable, expert pet care to pet owners worldwide. Priced at $49 CAD, $35 USD, and £30 GBP per consultation, this rollout offers 24/7 access to world-class Australian veterinarians at a fraction of traditional costs. Founded by CEO Josh Fidrmuc, Dial A Vet has revolutionized pet care in Australia since its inception. Now, Fidr...

DALLAS--(BUSINESS WIRE)--Evette, today’s leading nationwide veterinary relief staffing agency, announced the expansion of its leadership team, naming Dr. Eric Mueller, DVM, as Vice President of Clinical Operations. The appointment of Evette’s first-ever internal DVM comes as the company continues on a path of rapid growth and innovation in the veterinary industry, and reinforces its commitment to amplifying veterinarian voices. Dr. Eric Mueller comes to Evette with over a decade of wide-ranging...

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2024 ended February 2, 2025. Fiscal Q4 2024 Results (1): Net sales of $3.25 billion improved 14.9 percent year over year Gross margin of 28.5 percent expanded 30 basis points year over year Net income of $22.8 million, including share-based compensation expense and related taxes of $99...

DUBLIN--(BUSINESS WIRE)--The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course" has been added to ResearchAndMarkets.com's offering. Understanding the chemistry, manufacturing and controls (CMC) requirements for veterinary pharmaceuticals is essential to support successful registration in the EU Regulations for CMC of veterinary pharmaceuticals are complex and are regularly updated, making pharmaceutical product development challenging. I...

NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in the upcoming movie Shelter Me: The Cancer Pioneers. The movie offers a look into canine comparative oncology, a field that compares treatment of cancers in dogs to those in people, and covers developing treatments for rare forms of cancer. OST-HER2 is an immunotherapy for...

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today increased the quarterly common stock cash dividend to $.52 up from $.50 per share. The increase will be effective in the second quarter, 2025. The Board declared that the second quarter dividend is to be paid on May 15, 2025 to shareholders of record as of April 17, 2025. On an annual basis, the new dividend rate is $2.08 vs. $2.00 per share previously. The Company has paid uninterrupted dividends on...

BERWYN, Penn.--(BUSINESS WIRE)--Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today announced positive results from a beagle dog dose range finding (“DRF”) study. Probudur is the company’s long-acting liposomal bupivacaine formulation injected at a wound site to provide both immediat...